Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
19.62
+0.16 (0.82%)
Nov 10, 2026, 4:00 PM EST - Market closed
Braveheart Bio Market Cap
Braveheart Bio has a market cap or net worth of $1.6 billion as of November 10, 2026. It is the 7,609th most valuable company in the world and the 1,917th biggest in the United States.
Market Cap
1.60B
Enterprise Value
1.48B
1-Year Change
n/a
Global Rank
Country Rank
#1,917 United States
Category
ChartMarket Cap Chart
Since the IPO on August 6, 2026, Braveheart Bio's market cap has increased from $1.27B to $1.60B, an increase of 25.94%. That is a compound annual growth rate of 140.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.60B | 0.82% |
| Nov 9, 2026 | 1.59B | 4.62% |
| Nov 6, 2026 | 1.52B | 6.80% |
| Nov 5, 2026 | 1.42B | -13.38% |
| Nov 4, 2026 | 1.64B | -6.01% |
| Nov 3, 2026 | 1.75B | 1.66% |
| Nov 2, 2026 | 1.72B | -2.19% |
| Oct 30, 2026 | 1.76B | 1.51% |
| Oct 29, 2026 | 1.73B | -2.62% |
| Oct 28, 2026 | 1.78B | -0.27% |
| Oct 27, 2026 | 1.78B | -0.23% |
| Oct 26, 2026 | 1.79B | 2.01% |
| Oct 23, 2026 | 1.75B | -0.19% |
| Oct 22, 2026 | 1.75B | 2.09% |
| Oct 21, 2026 | 1.72B | 3.80% |
| Oct 20, 2026 | 1.65B | 5.52% |
| Oct 19, 2026 | 1.57B | 2.67% |
| Oct 16, 2026 | 1.53B | -4.30% |
| Oct 15, 2026 | 1.60B | 1.09% |
| Oct 14, 2026 | 1.58B | 0.05% |
| Oct 13, 2026 | 1.58B | -5.06% |
| Oct 12, 2026 | 1.66B | 1.70% |
| Oct 9, 2026 | 1.63B | 4.87% |
| Oct 8, 2026 | 1.56B | 2.74% |
| Oct 7, 2026 | 1.52B | -6.11% |
| Oct 6, 2026 | 1.62B | -7.31% |
| Oct 5, 2026 | 1.74B | 0.38% |
| Oct 2, 2026 | 1.74B | -0.65% |
| Oct 1, 2026 | 1.75B | 5.99% |
| Sep 30, 2026 | 1.65B | -9.58% |
| Sep 29, 2026 | 1.82B | 6.03% |
| Sep 28, 2026 | 1.72B | 2.18% |
| Sep 25, 2026 | 1.68B | -11.77% |
| Sep 24, 2026 | 1.91B | 8.90% |
| Sep 23, 2026 | 1.75B | -9.11% |
| Sep 22, 2026 | 1.93B | -5.64% |
| Sep 21, 2026 | 2.04B | -14.32% |
| Sep 18, 2026 | 2.38B | 5.38% |
| Sep 17, 2026 | 2.26B | 0.95% |
| Sep 16, 2026 | 2.24B | 2.77% |
| Sep 15, 2026 | 2.18B | -1.15% |
| Sep 14, 2026 | 2.21B | 1.43% |
| Sep 11, 2026 | 2.17B | -2.24% |
| Sep 10, 2026 | 2.22B | -5.74% |
| Sep 9, 2026 | 2.36B | -1.70% |
| Sep 8, 2026 | 2.40B | 38.67% |
| Sep 4, 2026 | 1.73B | 1.79% |
| Sep 3, 2026 | 1.70B | -2.52% |
| Sep 2, 2026 | 1.74B | 2.55% |
| Sep 1, 2026 | 1.70B | 3.06% |
| Aug 31, 2026 | 1.65B | -7.07% |
| Aug 28, 2026 | 1.78B | -1.51% |
| Aug 27, 2026 | 1.80B | 0.36% |
| Aug 26, 2026 | 1.80B | 0.43% |
| Aug 25, 2026 | 1.79B | 0.51% |
| Aug 24, 2026 | 1.78B | -0.29% |
| Aug 21, 2026 | 1.79B | 0.58% |
| Aug 20, 2026 | 1.78B | -5.35% |
| Aug 19, 2026 | 1.88B | 8.30% |
| Aug 18, 2026 | 1.73B | -3.29% |
| Aug 17, 2026 | 1.79B | 2.33% |
| Aug 14, 2026 | 1.75B | 4.08% |
| Aug 13, 2026 | 1.68B | -0.69% |
| Aug 12, 2026 | 1.69B | 4.56% |
| Aug 11, 2026 | 1.62B | -9.15% |
| Aug 10, 2026 | 1.78B | -8.23% |
| Aug 7, 2026 | 1.94B | 52.73% |
| Aug 6, 2026 | 1.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 1.66B |
| Ultragenyx Pharmaceutical | 1.64B |
| Immunocore Holdings | 1.62B |
| Nanobiotix | 1.60B |
| uniQure | 1.53B |
| Nuvation Bio | 1.52B |
| Structure Therapeutics | 1.52B |
| Tyra Biosciences | 1.51B |